dragon
Scopus Index (2025)

Medical journal of wuhan university

Medical journal of wuhan university (ISSN:1671-8852) is a monthly peer-reviewed scopus-indexed journal from 2001 to present. The publisher of this journal is Science China Press. Medical journal of wuhan university committed to gathering and disseminating excellent research achievements. The journal welcomes all types of General Medicine journal includes Medicine,Pharmacy, Bio-Chemistry, Psychology,Public Health Etc.

Medical journal of wuhan university

Submission Deadline

  • ( Vol 46 , Issue 10 ) | 04 Dec 2025

    Day
    Hour
    Min
    Sec

Publication Date

  • ( Vol 46 , Issue 09 ) | 30 Nov 2025

Aim And Scope

Medical journal of wuhan university

General Medicine, Pharmacy, Bio-Chemistry, Psychology Sciences and Public health:

Anatomy, Physiology, Biochemistry, Pharmacology, Pathology, Forensic medicine, Microbiology, Community Medicine, Otorhinolaryngology, Internal Medicine, General Surgery, Obstetrics and Gynecology, Radiology, Pulmonary Medicine, Dermatology and Venereal diseases, Infectious Diseases, Anaesthesia, Cancer research, Neurosurgery, Orthopedics, Gastroenterology, Neurology, Nephrology, Medical education, Orthopaedics, Paediatrics, Reproduction, Cardiology, Diabetes, Surgery, Nursing, Otolaryngology, Dental, Psychology, Anesthesiology, Dermatology,
Endocrinology, Hepatology, Urology, Venereology, Psychiatry, Biotechnology, Pharmacy, ENT, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutics, Pulmonology, Pharmacognosy, Pharmaceutical, Phatmaceutical Technology, Biopharmaceutics, Pharmacokinetics Pharmacodynamics, Industrial Pharmacy, Drug Design, Quality Assurance, Drug Regulatory Affairs, Phytochemistry, Drug Delivery Systems, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology, Hospital Pharmacy, Clinical Pharmacy, Pharmacy Practice, Drug Discovery, Drug Metabolism, Toxicology, Clinical Research, Pharmacogenomics, Phrmacoinformatics, Pharmacovigilance, Life Sciences like Chemistry,
Biomedical Sciences, Microbiology, Immunology, Forensic, Epidemiology, Oncology, Biomedicine, Dentistry, Physiotherapy, Gynaecology, Dermatoepidemiology, Neuroscience, Ophthalmology, Sexology, Osteology, Kinesiology, Angiology/Vascular Medicine, Critical care Medicine, Haematology, Infectious Diseases and Vaccinology, Bariatrics, Pharmacy and Nursing, Pharmacognosy and Phytochemistry, Radiobiology, Clinical immunology, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Healthcare Services, Healthcare Management, Bioinformatics and Biotechnology, Geriatric Medicine,

Latest Paper Here

Medical journal of wuhan university
Prevalence of Diabetes Mellitus in long commuters of the urban population and the association of Stress –a cross- sectional study

The diabetes mellitus epidemic has evolved. The urban population commute for work. Commuting long hours for daily work is associated with comorbidities. Diabetes has many etiological factors. Long hours of commuting may also be the cause of diabetes. This study was initiated to study the prevalence of diabetes in people who commute long hours for work and to find the association of commute stress. 354 people who commute for work daily in a car participated in the study. The study population was divided into two categories, as long commuters (LC) and short commuters (SC). The stress of commute

Study of inflammatory markers in COVID-19 patients admitted to High Dependency Unit

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the coronavirus disease 2019 (COVID-19) has caught on like wildfire throughout the world. There is currently no effective therapy for its treatment. It is imperative to find specific indicators in order to track the development of the disease and provide patients with an early diagnosis and disease severity. To investigate the levels of inflammatory markers in COVID-19 patients admitted to high dependency unit, and their role in tracing disease progression. This observational analysis included 1595 patients of either

Asymptomatic Spleen Metastatic of Colorectal Cancer: An Unexpected Finding Following Adjuvant Treatment of Resectable Cases

Isolated splenic metastasis from colorectal cancer (CRC) is extremely rare, occurring in only 1.2–7.1% of cases, due to the spleen’s strong immune surveillance, lack of afferent lymphatic drainage, and unique blood flow. While metastasis typically spreads to the liver and lungs, haematogenous dissemination to the spleen can occur, though the exact mechanism remains unclear. Most cases are asymptomatic and discovered incidentally through imaging or rising carcinoembryonic antigen (CEA) levels. Treatment options include systemic chemotherapy, splenectomy, or a combination, depending on disea

The correlation of tumor site, KRAS mutation and mismatch repair (MMR) status on the survival outcome of colorectal carcinoma patient with conventional chemotherapy: a systematic review

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, and survival outcomes are influenced by tumor sidedness, KRAS mutation status, and mismatch repair (MMR) status. This systematic review evaluated the correlations between these factors and survival outcomes. We performed a comprehensive search of the PubMed, Cochrane Library, and Scopus databases identified studies on adult CRC patients by tumor sidedness, KRAS mutation status, and MMR status. Observational and interventional studies reporting the DFs, PFS, and OS were included. Twenty-eight studies (N = 169,582 pat

Association Between Remnant Cholesterol And Insulin Resistance With Metabolic-Associated Fatty Liver Disease (MAFLD) : Mini Review

Globally, the incidence of Metabolic Associated Fatty Liver Disease (MAFLD) has significantly grown due to the prevalence of obesity and rising consumption of refined carbohydrates and saturated fats. Numerous metabolic issues are largely caused by insulin resistance (IR), a condition in which the body's cells react poorly to the hormone insulin. Hepatic steatosis, or increased fat synthesis and storage in the liver, is a result of IR's alteration of normal glucose and lipid metabolism. Remnant cholesterol is increasingly recognized for its role in promoting liver inflammation in metabolic-ass

MJWU